260 CHARLES STREET, WALTHAM, MA
OptimizeRx Corporation Dismisses UHY LLP as Independent Accountant
Earnings Release
Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
Announces Leadership Team
Financial Results, Press Release
Appoints CEO Steve Silvestro to Board of Directors
Shareholder votes
Q3
Q2
Q1
FY 2024
Notice of Late Filing for Quarterly Report
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Definitive Additional Information Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload